Abstract
Vasogenic brain edema is a common diagnostic and management problem in brain tumor patients. Molecular mechanisms play a role in the pathophysiology, including abnormalities of tumor endothelium, vascular endothelial growth factor and leukotriene synthase. Edema diagnosis is facilitated by the development of neuroradiological imaging techniques, with diffusion-weighted imaging (DW-MRI) differentiating tumor grades or abscesses and tumors, and diffusion tensor imaging representing an advanced technique to potentially differentiate malignant glioma from metastasis or facilitate preoperative planning. Edema is a prognostic factor for meningioma and metastases but not for glioma. Therapy includes, amongst others, tumor-directed measures such as debulking surgery, radio- and chemotherapy. However, local therapeutic approaches might also induce or exacerbate edema formation. Peritumoral edema can usually be managed with corticosteroids. However, patients on corticosteroids are at greater risk of metabolic changes, Pneumocystis carinii pneumonia, and thromboembolism. More recently, inhibitors of cyclooxygenase-2 as well as boswellic acids have been explored as antiedema agents in patients with brain tumors.
Citations
Dec 25, 2007·Journal of Molecular Neuroscience : MN·Yaniv Assaf, Ofer Pasternak
Jun 21, 2005·Lancet Neurology·Patrick MitchellA David Mendelow
May 13, 2008·Nature Medicine·Nicolai E SavaskanIlker Y Eyüpoglu
Jan 13, 2010·The Neurologist·Marc C Chamberlain
Jun 4, 2005·Onkologie·Reinhold GrafKlaus Maier-Hauff
Sep 15, 2005·Onkologie·Wolfgang WickMichael Weller
Jun 26, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Maja A HofmannUwe Trefzer
Mar 13, 2012·Journal of Neurosurgery·Bodiabaduge A P JayasekeraPeter C Whitfield
May 24, 2011·Clinical Medicine Insights. Oncology·Marc C Chamberlain
Apr 1, 2014·Journal of Computer Assisted Tomography·Salmaan AhmedAnita Mahajan
Jan 14, 2009·Investigational New Drugs·Clovis O Da FonsecaThereza Quirico-Santos
May 28, 2014·Medical Oncology·Hai-long LiSong Lin
Nov 9, 2005·Expert Review of Neurotherapeutics·Christina Stewart-Amidei
Aug 15, 2009·Expert Opinion on Investigational Drugs·Jennifer A MoliternoSusan C Pannullo
Mar 26, 2016·Neurosurgery Clinics of North America·Malte MohmeSven Oliver Eicker
Sep 21, 2013·Magnetic Resonance Imaging·Mohammad Sabati, Andrew A Maudsley
Sep 10, 2011·Revue neurologique·L TaillandierE Le Rhun
Aug 8, 2007·European Journal of Radiology·Osamu TogaoHiroshi Honda
May 4, 2007·Journal of the Neurological Sciences·Ramachandran RamnarayanNikolai G Rainov
Aug 18, 2009·Cancer Science·Tobias EngelhornIlker Y Eyüpoglu
May 30, 2006·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·H Neeb, N J Shah
Jun 22, 2010·Cancer·Marc C Chamberlain
Aug 1, 2013·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Xiaowei Zou, Truman R Brown
May 3, 2006·NeuroImage·H NeebN J Shah
Sep 18, 2015·Journal of Neuroinflammation·Stavros PolyzoidisTheoharis C Theoharides
Jul 6, 2015·Current Treatment Options in Oncology·Jeffrey J Raizer, Karan S Dixit
Jul 18, 2008·NeuroImage·H NeebN J Shah
Feb 3, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·É Le RhunL Taillandier
Apr 21, 2009·Natural Product Reports·Bhahwal Ali ShahSubhash Chandra Taneja
Dec 3, 2010·Deutsches Ärzteblatt International·Thomas SchneiderRaimund Firsching
Feb 5, 2019·ACS Nano·Hamed AramiSanjiv S Gambhir